Six days after the onset of influenza B symptoms, a 14-year-old Japanese boy presented with encephalopathy-like symptoms, somnolence, irritability, and childishness, which we first considered was an atypical type of influenza-associated encephalopathy because the infection symptoms disappeared by day 4. His encephalopathy-like symptoms gradually improved, although he had repetitive hypersomnia attacks. Owing to the patient's clinical presentation and normal interleukin-6 levels in the cerebrospinal fluid during the first period of hypersomnia, we diagnosed him with Kleine-Levin syndrome (KLS) triggered by influenza B. The preceding influenza infection was not only a diagnostic clue of KLS but also a diagnostic confounding factor.
Introduction
Recurrent hypersomnia, which is a rare disorder that causes recurring periodic episodes of hypersomnia, has a male predominance with a typical age of onset in the teenage years (1) . Kleine-Levin syndrome (KLS) is a disorder that is classified as a subtype of recurrent hypersomnia and that presents with recurrent hypersomnia plus binge eating, hypersexuality, cognitive disturbances, and/or odd behavior (1, 2) . Various infections often precede the onset and reoccurrence of KLS (2, 3) , although the infectious agents have rarely been identified (4) (5) (6) (7) (8) . Patients with KLS often present with cognitive disturbances, mood disorders, and irritability (1, 2) , and, thus, they are sometimes misdiagnosed as psychiatric disorders or encephalopathy (9) . In this paper, we report on a 14-year-old Japanese boy who presented with normal interleukin-6 (IL-6) levels and slightly decreased levels of hypocretin in the cerebrospinal fluid (CSF) during the first attack of KLS, which occurred just after an influenza B infection, and, thus, his disorder was confused with influenza-associated encephalopathy.
Case Report
A previously healthy 14-year-old Japanese boy who had no family history of hypersomnia presented with high-grade fever, cough, and general fatigue in March 2011. He was diagnosed with influenza B by a rapid antigen test that was performed the following day, and he was treated with zanamivir inhalation (10 mg, twice daily). His symptoms disappeared on day 4, but he was somnolent all day after day 6. He exhibited disturbed concentration, cried, and on day 7, said, "I cannot concentrate on studying." Brain computed tomography (CT) and magnetic resonance imaging (MRI) scans that were performed at another hospital detected no abnormal findings on day 8. Influenza-associated encephalopathy was suspected, and he was transferred to our hospital for intensive care on day 9.
Upon admission, findings from a physical examination showed a temperature of 36.0 , a pulse of 70 beats/min, and a blood pressure of 116/66 mmHg. No abnormal find- Figure 1 . Results from the electroencephalogram (EEG) that was performed during the first hypersomnia attack that was triggered by influenza B (day 9). The EEG shows a slightly diffuse slowing of basic activity without epileptic abnormalities. ings were detected in the chest or abdomen. He was somnolent most of the day and was sleeping while speaking. In addition, he was irritable and cried like a preschool-aged child during the physical and clinical examination. The cranial nerves were intact. Paresis, sensory disturbances, ataxia, and meningeal and myelopathic signs were not detected. Findings from laboratory examinations, including blood counts, electrolytes, and liver and kidney function tests, were all within normal limits. The levels of C-reactive protein were 0.02 mg/dL; blood sugar, 98 mg/dL; and ammonia, 22 μg/dL. Thyroid function, antithyroid antibodies, antinuclear antibody, anti-DNA antibody, and complement activity were negative and normal. An analysis of the CSF demonstrated white blood cell counts of 2 cells/mm 3 (monocytes), a protein concentration of 36 mg/dL, an IgG concentration of 3.5 mg/dL, and a sugar concentration of 61 mg/dL with normal pressure. Chest X-ray showed normal findings. An electroencephalogram (EEG) showed a slightly diffuse slowing of basic activity without epileptic abnormalities ( Fig. 1) . We diagnosed him with atypical influenzaassociated encephalopathy because he was afebrile, and the acute phase of influenza was terminated. A 3-day regimen of high-dose intravenous methylprednisolone (1 g/day) was initiated from the day of admission. A single intravenous injection of 600 mg of peramivir was also administered. His somnolence, irritability, and childishness gradually improved, and he was alert on day 12 and said, "I felt like I was dreaming and do not have any memory of the state of somnolence." He was discharged on day 14, although he was somnolent again from day 42 and readmitted on day 47. Upon physical and neurological examinations, no abnormal findings were detected except for somnolence, irritability, and childishness. Blood tests were normal, including tumor marker levels. Brain CT and MRI detected no abnormal findings, including in the hypothalamus, and the EEG again showed a slightly diffuse slowing of basic activity. Encephalopathy of unknown origin was suspected, but his somnolence, irritability, and childishness gradually decreased, and he was alert on day 51 without any therapy. However, a third somnolent attack occurred 1 month later. We diagnosed him with KLS due to his clinical presentation, recurrent hypersomnia, cognitive disturbances, irritability, and childish behavior according to the diagnostic criteria of the International Classification of Sleep Disorders II (ICSD-2) for recurrent hypersomnia, and his disorder was believed to be triggered by influenza B (1). In the analysis of the CSF that was performed during the first attack of KLS (day 9), IL-6 levels were not elevated (0.7 pg/mL), and tests for the oligoclonal band and anti-influenza B antibody were negative. Hypocretin levels in the CSF during the first attack of KLS were 189 pg/mL (normal, 200 pg/mL or more; intermediate, 110-200 pg/mL; low/undetectable, 110 pg/mL or less). We could not reexamine the CSF hypocretin levels during the other symptomatic and asymptomatic periods because of his and his family's refusal. The symptoms of KLS disappeared about 1 week later, and the EEG findings were normal during the asymptomatic period. He had the fourth attack of KLS on day 98, and he was treated with methylphenidate (18 mg once daily). Methylphenidate slightly decreased the degree of sleepiness, but he has had repetitive hypersomnia attacks monthly for 6 months.
Discussion
KLS is a rare disorder that consists of recurring periodic hypersomnia episodes that last more than 2 days and less than 4 weeks, binge eating, hypersexuality, cognitive disturbances, and/or odd behavior (1). Theoretically, it is possible to diagnose recurrently hypersomnic patients with KLS from the second hypersomnia attack onward, although they are sometimes misdiagnosed as psychiatric disorders or encephalopathy due to the rarity of KLS and the psychiatric and encephalopathy-like symptoms (9) . About one-quarter of patients with KLS experience a precipitating flu-like fever before the onset and reoccurrence of the hypersomnia attack (2). A strong relationship between an upper respiratory infection and the first attack of KLS has recently been reported (3), although identification of the infectious agents has been very rare (4) (5) (6) (7) (8) . The clinical profiles of 5 patients who were reported to have KLS that was triggered by identified infectious agents are summarized in Table 1 . All of them were male and teenagers, which was consistent with typical KLS patients. Infections of streptococci and various viruses preceded the onset and recurrence of KLS. Except for 1 patient of the 5, infection preceded the first attack of KLS. The symptoms of KLS occurred between 3 and 7 days after the onset of infection symptoms. Patients presented with various cognitive and psychiatric symptoms in addition to hypersomnia. Therefore, 1 patient was misdiagnosed with viral meningitis at first (7), and 2 patients were diagnosed (4, 6). The current patient presented with typical KLS symptoms 6 days after the onset of infection symptoms, as did other patients with KLS that were triggered by identified infectious agents, although we could not discriminate the first attack of KLS from influenza-associated encephalopathy because of the encephalopathy-like symptoms and EEG findings. Patients with influenza-associated encephalopathy present with altered or loss of consciousness and sometimes abnormal behavior (10) . However, the timing of the onset and his age were different from that seen in typical influenza-associated encephalopathy. Influenza-associated encephalopathy usually occurs 1 or 2 days after the onset of fever in children under the age of 5 years old (10) . Typical KLS occurs between 3 and 5 days after the onset of fever in teenagers (2) , and this was consistent with the clinical presentation of the current patient. The main pathology of influenza-associated encephalopathy is increased levels of cytokines, including IL-6, in the CSF and serum (11) . There have been no examinations of the levels of cytokines, including IL-6, in patients with KLS, although white cell counts and protein levels in the CSF are normal (2) . The fact that IL-6 levels in the CSF were not increased in our patient even 1 week after the influenza B infection suggested that his pathophysiology was different from that of influenza-associated encephalopathy.
Narcolepsy is another representative hypersomnia disorder, which is characterized by irresistible bouts of sleep in the daytime, cataplexy, sleep attacks, and hypnagogic hallucinations. An association with a preceding influenza infection, especially the 2009 H1N1 influenza, and narcolepsy was recently reported in China (12) . The onset of narcolepsy is assumed to be delayed by about 6 months after the influenza infection, suggesting that the preceding influenza infection initiates and activates an immune response that induces the onset of narcolepsy (12) . Autoimmune mechanisms have also been postulated as one of the causes of KLS (13) , but the tests for oligoclonal band and anti-influenza antibody in the CSF were negative at the onset of KLS in the present patient. Steroid pulse therapy was given during the first attack of KLS, but we could not determine the effects of the steroid therapy.
Dysfunction of the hypothalamus has also been suggested as one of the sites of pathophysiology in KLS (6). Hypocretin, which is a neuropeptide that is generated by hypothalamic neurons, regulates sleep-wake rhythms and feeding (14) . A marked decrease of CSF hypocretin levels is the hallmark of narcolepsy (15) . The measurement of CSF hypocretin levels in other types of hypersomnia has been attempted, but studies of patients with KLS are limited, especially during the symptomatic period. Hypocretin levels were normal during asymptomatic intervals in patients with KLS (16) and during symptomatic periods in some patients (17) . However, hypocretin levels during symptomatic periods in 2 patients with KLS were relatively low compared to the levels during the asymptomatic period, which were within normal or intermediate levels (18, 19) . We measured hypocretin levels during the first attack of KLS, which occurred just after the influenza B infection, and the levels were intermediate. Although the meaning of the slightly decreased levels of hypocretin during the first attack of KLS was limited because we could not reexamine the hypocretin levels during subsequent symptomatic and asymptomatic periods, the slightly decreased hypocretin levels may contribute to the onset of KLS. Further investigation is needed to elucidate the pathophysiology of KLS.
In this paper, we report a 14-year-old Japanese boy who was affected by KLS just after an influenza B infection. At the third hypersomnia attack, KLS was suspected for the first time. The preceding influenza infection was not only a diagnostic clue of KLS, but also one of the diagnostic confounding factors. A first attack of KLS that is triggered by influenza should be considered in patients presenting with atypical features of influenza-associated encephalopathy, such as delayed onset and no findings of inflammation. Slightly decreased levels of hypocretin may play a part in the onset of KLS, and, thus, the measurement of the levels of IL-6 and hypocretin in the CSF may help in the early differential diagnosis of KLS from influenza-associated encephalopathy.
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